CMBA
AMRX icon

C.M. Bidwell & Associates’s Amneal Pharmaceuticals AMRX Stock Holding History

C.M. Bidwell & Associates’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.7K Buy
+5,415
New +$74.2K 0.04% 180
2025
Q4 		– Sell
-65
Closed -$651 – 487
2025
Q3 		$651 Hold
65
– – ﹤0.01% 459
2025
Q2 		$526 Buy
+65
New +$490 ﹤0.01% 418
2020
Q3 		– Sell
-29,550
Closed -$141K – 453
2020
Q2 		$141K Buy
+29,550
New +$122K 0.13% 166

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

C.M. Bidwell & Associates's AMRX Position: Q2 2026 in Review

C.M. Bidwell & Associates opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 5,415 shares worth $93.7K. The stake represents 0.04% of the portfolio and ranks #180 among its holdings. This is a return to the name: C.M. Bidwell & Associates previously reported a position in AMRX as recently as Q3 2025.

C.M. Bidwell & Associates first reported a position in AMRX in Q2 2020 and has held it in 4 quarters since. The position peaked at $141K in Q2 2020. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • C.M. Bidwell & Associates held 5,415 shares of Amneal Pharmaceuticals worth $93.7K as of Q2 2026.
  • Amneal Pharmaceuticals was a new C.M. Bidwell & Associates position in Q2 2026.
  • Amneal Pharmaceuticals made up 0.04% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #180 holding.
  • C.M. Bidwell & Associates first reported a position in Amneal Pharmaceuticals in Q2 2020 and has held it in 4 quarters since.
  • C.M. Bidwell & Associates's Amneal Pharmaceuticals position peaked at $141K in Q2 2020.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.